BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5914113)

  • 1. Radiocopper studies in patients with Wilson's disease and their relatives.
    Tauxe WN; Goldstein NP; Randall RV; Gross JB
    Am J Med; 1966 Sep; 41(3):375-80. PubMed ID: 5914113
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
    Hamamoto K; Tauxe WN; Novak LP; Goldstein NP
    J Lab Clin Med; 1968 Nov; 72(5):754-9. PubMed ID: 5697385
    [No Abstract]   [Full Text] [Related]  

  • 3. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
    O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L
    Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862
    [No Abstract]   [Full Text] [Related]  

  • 5. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
    Fitzgerald MA; Gross JB; Goldstein NP; Wahner HW; McCall JT
    Mayo Clin Proc; 1975 Aug; 50(8):438-42. PubMed ID: 1152537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease.
    Osborn SB; Walshe JM
    Lancet; 1967 Feb; 1(7486):346-50. PubMed ID: 4163882
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies with radiocopper (64Cu) in Wilson's disease: dynamics of copper transport.
    Osborn SB; Walshe JM
    Clin Sci; 1965 Dec; 29(3):575-81. PubMed ID: 5848709
    [No Abstract]   [Full Text] [Related]  

  • 8. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of Wilson's disease in sibs of a patient with Wilson's disease.
    Kamoun P; Cadoudal M; Rabier D; Jérôme H
    Clin Chem; 1986 Feb; 32(2):392. PubMed ID: 3943210
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pigment cirrhosis of the liver. I. Wilson's disease--hepatolenticular degeneration].
    Koziolowa H; Dziezbicka E
    Pol Arch Med Wewn; 1975 Nov; 54(5):491-5. PubMed ID: 1197060
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper.
    O'Reilly S; Weber PM; Oswald M; Shipley L
    Arch Neurol; 1971 Jul; 25(1):28-32. PubMed ID: 5146408
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary copper excretion and hepatic copper concentrations in liver disease.
    Frommer DJ
    Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Wilson's disease and its treatment have taught us about the metabolism of copper. Observations in 27 cases.
    Goldstein NP; Tauxe WN; McCall JT; Randall RV; Gross JB
    Med Clin North Am; 1968 Jul; 52(4):989-1001. PubMed ID: 5742073
    [No Abstract]   [Full Text] [Related]  

  • 15. Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease.
    Oga M; Matsui N; Anai T; Yoshimatsu J; Inoue I; Miyakawa I
    Am J Obstet Gynecol; 1993 Jul; 169(1):196-8. PubMed ID: 8333453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilson's disease (hepatolenticular degeneration). Treatment with penicillamine and changes in hepatic trapping of radioactive copper.
    Goldstein NP; Tauxe WN; McCall JT; Randall RV; Gross JB
    Arch Neurol; 1971 May; 24(5):391-400. PubMed ID: 5554863
    [No Abstract]   [Full Text] [Related]  

  • 17. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 19. Wilson's disease.
    Walshe JM
    Biochem J; 1969 Feb; 111(3):8P-9P. PubMed ID: 5767059
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.